Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Point-Of-Care-Testing (POCT) Market in 2026, and what figure is it projected to hit by 2030?
The point-of-care-testing (poct) market has experienced swift expansion over recent years. Forecasts indicate it will increase from $50.79 billion in 2025 to $56.68 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical expansion of this market stems from several factors, including the escalating prevalence of chronic diseases, a growing necessity for rapid clinical decision-making, the development of emergency and critical care services, limited access to centralized laboratories, and the demand for immediate diagnostic results.
The market for point-of-care-testing (poct) is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $86.91 billion by 2030, demonstrating an 11.3% compound annual growth rate (CAGR). Factors driving this growth during the projection period include advancements in poct device miniaturization, the increase in home care and remote patient monitoring services, the proliferation of infectious disease outbreaks, the decentralization of healthcare, and the increasing uptake of self-testing diagnostics. Key trends anticipated for this forecast span include the increasing use of rapid diagnostic testing at the point of care, heightened demand for home-based and self-testing solutions, the broadening availability of over-the-counter diagnostic products, a greater emphasis on early disease detection and screening, and enhancements in the accuracy and sensitivity of poct devices.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp
Which Drivers Are Affecting Market Participation In The Point-Of-Care-Testing (POCT) Market?
The future expansion of the point-of-care-testing (POCT) market is anticipated to be fueled by the rising integration of telemedicine. Telemedicine involves providing healthcare services from a distance, leveraging digital communication tools like video calls, phone calls, or encrypted messages. The increased uptake of telemedicine stems from a growing need for accessible, prompt, and touchless healthcare, a trend significantly hastened by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift and dependable diagnostic data, which can be shared immediately with medical professionals located remotely. As an illustration, in April 2025, data from the American Hospital Association, a professional organization company in the US, indicated that over 12.6% of Medicare beneficiaries used telehealth services in 2023. Projections show that by 2036, the physician count will rise to 86,000. Telehealth is crucial in addressing the growing scarcity of physicians. Consequently, the expanding use of telemedicine is propelling the point-of-care-testing (POCT) market forward.
What Segment Categories Are Covered In The Point-Of-Care-Testing (POCT) Market?
The point-of-care-testing (poct) market covered in this report is segmented –
1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types
2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products
3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing
4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users
Subsegments:
1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices
2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing
3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing
4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing
5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing
6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing
7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing
8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing
Which Trends Are Influencing The Development Of The Point-Of-Care-Testing (POCT) Market?
Leading entities within the point-of-care testing (POCT) market are increasingly prioritizing technological advancements, notably microfluidic rapid antimicrobial-susceptibility testing (AST) systems, in response to the rising demand for quicker, clinic-based diagnostics and enhanced antimicrobial management in primary healthcare settings. This microfluidic AST technology utilizes fluid pathways at the micrometer dimension to cultivate and identify bacteria in patient specimens, like urine, and ascertain their antibiotic susceptibility significantly faster than traditional culture-based approaches, which often span multiple days. As an illustration, in June 2023, Sysmex Corporation, a Japanese diagnostics firm, launched the PA 100 AST System. This compact POCT analyzer integrates Sysmex Astrego’s exclusive microfluidic cartridges to identify bacteria in roughly 15 minutes and deliver full AST outcomes within approximately 30 minutes. The system boasts significant ease of use: medical practitioners merely place the sample into a disposable cartridge, insert it into the desktop analyzer, and obtain automated AST reports without requiring specialized lab expertise. This swift processing enables prompt antibiotic choices during the initial patient consultation, thereby aiding initiatives to decrease unsuitable prescriptions and counteract antimicrobial resistance (AMR).
Which Key Market Players Are Investing In Expansion And Innovation Within The Point-Of-Care-Testing (POCT) Market?
Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report
Which Regions Are Projected To Dominate The Point-Of-Care-Testing (POCT) Market In The Coming Years?
North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point-Of-Care-Testing (POCT) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp
Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company
Precast Construction Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report
Modular And Prefabricated Nonresidential Building Construction Global Market Report 2026
Ready Mix Concrete Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company